Drugs · Entity Annotation Prototype (beta)

3articles mentioning drugs

3drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Janus kinase (JAK) inhibitors ×

Janus kinase (JAK) inhibitors

This drug is selected. Its supporting articles are shown below.

Janus kinase (JAK) inhibitors3

Articles mentioning Janus kinase (JAK) inhibitors

3 articles · page 1 of 1

Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry

rmdopen · abstract · 2026-05-18 · 1 matching annotations

75.6%

interleukin 6 inhibitors b/tsDMARDs tumour necrosis factor inhibitors CTLA4-Ig Janus kinase (JAK) inhibitors rheumatoid arthritis b/tsDMARDs

… The proportion ineligible differed by b/tsDMARDs, highest with interleukin 6 inhibitors (47.4%) and CTLA4-Ig (45.1%) and lowest with Janus kinase (JAK)…

Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experience

rmdopen · abstract · 2026-02-11 · 1 matching annotations

85.5%

Janus kinase (JAK) inhibitors Takayasu arteritis BIOTAK registry conventional immunosuppression refractory disease

…he data from the BIOTAK registry of multicentre experience with Janus kinase (JAK) inhibitors in 20 patients with refractory TAK, demonstrating promising eff…

Subcorneal pustular dermatosis masquerading as eczematous dermatitis: a case report and mechanistic review

bmjcr · abstract · 2025-07-31 · 1 matching annotations

77.1%

infliximab dupilumab dapsone Janus kinase (JAK) inhibitors prurigo nodularis atopic dermatitis eczematous dermatitis tumour necrosis factor-alpha (TNFα) inhibitors neutrophilic dermatosis subcorneal pustular dermatosis+1 more

… experienced a dramatic and sustained clinical improvement with infliximab. This case highlights the diagnostic challenges posed by atypic…